These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11582913)

  • 1. [Treatment of meningococcal purpura fulminans].
    Leclerc F; Noizet O; Dorkenoo A; Cremer R; Leteurtre S; Sadik A; Fourier C
    Arch Pediatr; 2001 Sep; 8 Suppl 4():677s-688s. PubMed ID: 11582913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meningococcal purpura fulminans in children].
    Leclerc F; Binoche A; Dubos F
    Rev Prat; 2004 May; 54(9):957-62. PubMed ID: 15296272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.
    Ettingshausen CE; Veldmann A; Beeg T; Schneider W; Jäger G; Kreuz W
    Semin Thromb Hemost; 1999; 25(6):537-41. PubMed ID: 10632475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of purpura fulminans and early therapeutic recommendations].
    Reinert P
    Arch Pediatr; 2001 Sep; 8 Suppl 4():673s-676s. PubMed ID: 11582912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of protein C following infusion of protein C concentrate in children with severe meningococcal sepsis and purpura fulminans: a randomized, double-blinded, placebo-controlled, dose-finding study.
    de Kleijn ED; de Groot R; Hack CE; Mulder PG; Engl W; Moritz B; Joosten KF; Hazelzet JA
    Crit Care Med; 2003 Jun; 31(6):1839-47. PubMed ID: 12794428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
    Nadel S; De Munter C; Britto J; Habibi P; Levin M
    Crit Care Med; 1998 May; 26(5):971-2; author reply 972-3. PubMed ID: 9590331
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
    Zenz W; Bodó Z; Zobel G; Fanconi S; Rettenbacher A
    Crit Care Med; 1998 May; 26(5):969-71; author reply 972-3. PubMed ID: 9590330
    [No Abstract]   [Full Text] [Related]  

  • 8. Purpura fulminans in children: report of two cases.
    Hwang CC; Jaing TH; Chiu CH
    Acta Paediatr Taiwan; 1999; 40(2):119-20. PubMed ID: 10910600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant tissue plasminogen activator in children with meningococcal purpura fulminans--role uncertain.
    Baines P; Carrol ED
    Crit Care Med; 2004 Aug; 32(8):1806-7. PubMed ID: 15286574
    [No Abstract]   [Full Text] [Related]  

  • 10. [Physiopathology and curative treatment of meningococcal diseases: current aspects].
    Senneville E; Baclet V
    Pathol Biol (Paris); 2002 Dec; 50(10):613-9. PubMed ID: 12504371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Meningococcal purpura fulminans: treatment with recombinant protein C activator in 3 cases].
    Salinas U; Unzueta J; Vidarte MA; Rodrigo MP; Gómez JJ; Aguilera L
    Rev Esp Anestesiol Reanim; 2007 Oct; 54(8):503-6. PubMed ID: 17993100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
    Aiuto LT; Barone SR; Cohen PS; Boxer RA
    Crit Care Med; 1997 Jun; 25(6):1079-82. PubMed ID: 9201064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant tissue plasminogen activator restores perfusion in meningococcal purpura fulminans.
    Horne MD
    Crit Care Med; 1997 Jun; 25(6):909. PubMed ID: 9201041
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of purpura fulminans apropos of 21 cases: diagnostic delay and therapeutic problems].
    Menif K; Hamdi A; Khaldi A; Bouziri A; Kazdaghli K; Bel Hadj S; Kechrid A; Ben Jaballah N
    Tunis Med; 2007 May; 85(5):371-5. PubMed ID: 17657920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy in adult meningococcal purpura fulminans with acute renal failure and severe perfusion deficits to the extremities.
    Pechlaner C; Buratti T; Biedermann H; Joannidis M; Wiedermann CJ
    Wien Klin Wochenschr; 1999 Sep; 111(16):650-4. PubMed ID: 10510843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacterial meningitis and purpura fulminans in the child].
    Bourrillon A
    Rev Prat; 2001 Nov; 51(17):1898-902. PubMed ID: 11787221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Meningococcal sepsis in 3 young men].
    Diet F; Hartmann P; Lang A; Fätkenheuer G; Diehl V; Erdmann E
    Dtsch Med Wochenschr; 1999 Apr; 124(14):424-8. PubMed ID: 10230384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for death in meningococcal disease.
    Olivares R; Bouyer J; Hubert B
    Pathol Biol (Paris); 1993 Feb; 41(2):164-8. PubMed ID: 8327268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined antithrombin and protein C supplementation in meningococcal purpura fulminans: a pharmacokinetic study.
    Fourrier F; Leclerc F; Aidan K; Sadik A; Jourdain M; Tournoys A; Noizet O
    Intensive Care Med; 2003 Jul; 29(7):1081-7. PubMed ID: 12761614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile Henoch-Schönlein purpura.
    Wong CT; Harrington JW
    Emerg Med Australas; 2004 Jun; 16(3):225-8. PubMed ID: 15228466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.